Vanderbilt Human Research Protection Program
Institutional Biosafety Committee-Human Subjects
NIH Registration Number TN00040
The IBC-HS Committee meets the third Friday of the month from 8:30 to 10:30 am. Meeting locations are subject to change. Please call the VHRPP office to confirm meeting location (322-2918).
Effective – July 22, 2022
VOTING MEMBERS (10)
Antonios Hatzopoulos, PhD - Chair
Allison Wheeler, M.D., MSCI - Vice Chair
Richard DiTullio, PhD
Rolinda Bailey, BSMT(ASCP)
Cary Fu, M.D.
Douglas Johnson, M.D., MSCI
Jonathan Lehman, MD, PhD
Lori Rolando, MD, MPH, FACOEM
Donna Torr, PharmD
Kimberly Towers, BS
Cell & Developmental Biology
Hematology/Oncology
Biological Safety
Safety Officer TN Dept of Health
Neurology, Pediatric
Hematology/Oncology
Hematology/Oncology
Occupational Health
Pharmacy
Law Enforcement, Community Member
Vanderbilt’s Institutional Biosafety Committee-Human Subjects (IBC-HS) is authorized by the National Institutes of Health (NIH) to approve research projects involving the use of recombinant DNA and synthetic nucleotide research involving humans. Use the IBC application that is embedded in the IRB application and guidelines to submit proposals to the IBC-HS. If you need help in completing and IBC-HS application, contact the IRB to have the a member of the IBC-HS team to assist you.
-
Jennifer Bounds - Homemaker, Community Member
Brenton Harrison, BBA - Business, Community Member
Carrie Kitko, M.D. - Hematology/Oncology, Pediatric
Meryk Moore, PharmD - Pharmacy
Ray Peebles, M.D. - Pathology, Microbiology and Immunology